期刊文献+

血清GPBB早期诊断蒽环类药物的心脏毒性 被引量:1

Serum GPBB as a Marker for Early Detection for Anthracycline-induced Cardiotoxicity in Rabbits
下载PDF
导出
摘要 【目的】研究血清GPBB浓度是否可以成为蒽环类药物的心脏毒性早期诊断指标。【方法】新西兰雄性兔44只,随机分为对照组(8只)和实验组(36只)。对照组新西兰兔注射等体积的生理盐水;实验组新西兰兔每次静脉注射阿霉素2mg/kg,每周1次,根据实验周数不同,实验组分为4组,分别为1周组(8只)、2周组(8只)、4周组(9只)和8周组(11只)。经胸超声心动图测量左室射血分数(LVEF)和左室短轴缩短分数(FS)以及E峰和A峰比率。血清GPBB浓度测量采用ELISA方法。心肌光镜Billingham评分和电镜检查评价阿霉素心脏毒性。【结果】8周组新西兰兔LVEF、FS和E/A比率均下降(P<0.05)。4周组新西兰兔血清GPBB浓度明显高于对照组血清GPBB浓度[(30±8)ng/mLvs(21±8)ng/mL,P<0.05];8周组新西兰兔GPBB浓度为(38±3)ng/mL,显著高于其余各组新西兰兔血清GPBB浓度(P<0.05)。光镜下4周组新西兰兔心肌损害比对照组、1周组和2周组新西兰兔心肌损害严重(P<0.05);8周组新西兰兔心肌损害最严重(P<0.05)。电镜下线粒体水肿或断裂可见于2周组、4周组和8周组新西兰兔。血清GPBB浓度与阿霉素累积剂量(r=0.442,P<0.001)和心肌损害程度(r=0.467,P<0.001)均呈正相关。【结论】血清GPBB浓度可能是兔阿霉素心脏毒性较早期诊断指标。 [Objective] This study was to assess whether serum GPBB level could be a useful marker for the early detection of anthracycline-induced cardiotoxicity.[Methods] Forty-four male rabbits were entered into the study.Eight rabbits were randomly selected to form control group(saline control).The remaining animals were randomly selected to create groups 1-4.Thus,group 1 through 4 received intravenous injections of 2 mg/kg doxorubicin at weekly intervals of 1 week(group 1,8 rabbits),2 weeks(group 2,8 rabbits),4 weeks(group 3,9 rabbits),or 8 weeks(group 4,11 rabbits).Echocardiography was performed to measure left ventricular ejection fraction(LVEF),shortening fraction(FS),and E/A ratio.Serum GPBB concentrations were quantified by a rabbit-specific enzyme-linked immunosorbant assay(ELISA).Cardiotoxicity scores were assessed by light microscopy using the method of Billingham and also by electron microscopy.[Results] Decreased LVEF,FS,and E/A ratios were detected in group 4(P 0.05).Compared with control group,serum GPBB levels significantly increased in group 3(30 ± 8 ng/mL vs 21 ± 8 ng/mL,P 0.05).Serum GPBB levels in group 4 were 38 ± 3 ng/mL,which were higher than those in the other groups(P 0.05).Myocardial lesions in group 3 were significantly more severe than those in control group,group 1 and group 2(P 0.05).Myocardial lesions were the most severe in group 4(P 0.05).Mitochondria swell or disruption was demonstrable by electron microscopy in group2,group3,and group 4.There was a positive correlation between serum GPBB levels and the doses of doxorubicin(r = 0.442,P 0.001) and cardiomyopathy scores(r = 0.467,P 0.001).[Conclusions] Serum GPBB concentrations appear to provide a sensitive method for assessing early cardiotoxicity of doxorubicin in rabbits.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2011年第2期197-202,共6页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广州市科委基金(2004Z3-E0551)
关键词 糖原磷酸化酶BB型同功酶 心脏毒性 蒽环类药物 阿霉素 GPBB cardiotoxicity anthracycline doxorubicin
  • 相关文献

参考文献15

  • 1Oeffinger KC,Mertens AC,Sklar CA,et al.Chronic health conditions in adult survivors of childhood cancer[J].N Engl J Med,2006,355(15):1572-1582.
  • 2Jemal A,Siegel R,Ward E,et al.Cancer statistics,2006[J].CA Cancer J Clin,2006,56(2):106-130.
  • 3Ganz WI,Sridhar KS,Ganz SS,et al.Review of tests for monitoring doxorubicin-induced cardiomyopathy[J].Oncology,1996,53(6):461-470.
  • 4Meinardi MT,van der Graat WT,van veldhuisen D J,et al.Detection of anthracycline-induced cardiotoxicity[J].Cancer Treat Rev,1999,25(4):237-247.
  • 5Mair J.Glycogen phosphorylase isoenzyme BB to diagnose ischaemic myocardial damage[J].Clin Chim Acta,1998,272(1):79-86.
  • 6Peetz D,Post F,Schinzel H,et al.Glycogen phosphorylase BB in acute coronary syndromes[J].Clin Chem Lab Med,2005,43(12):135-1358.
  • 7Horacek JM,Tichy M,Rudil R,et al.Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity[J].Ann Oncol,2008,19(9):1656-1657.
  • 8Horacek JM,Jebavy L,Ulrychova M,et al.Glycogen phosphorylase BB could be a new biomarker for detection of cardiac toxicity during hematopoietic cell transplantation for hematological malignancies[J].Bone Marrow Transplant,2010,45(6):1123-1124.
  • 9Horacek JM,Vasatova M,Tichy M,et al.The use of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high-dose chemotherapy for acute leukemia[J].Exp Oncol,2010,32(2):97-99.
  • 10Billingham ME,Mason JW,Bristow MR,et al.Anthracycline cardiomyopathy monitored by morphologic changes[J].Cancer Treat Rep,1978,62(6):865-872.

二级参考文献6

  • 1李文强,李艳,魏捷,李国草,李庚山.扩张型心肌病家兔血浆脑钠肽水平的改变及其意义[J].中国危重病急救医学,2005,17(3):161-164. 被引量:16
  • 2Singal PK, Iliskovic N. Doxorubicin2induced cardiomyopathy [J]. N Engl J Med, 1998, 339: 900-905.
  • 3Hrdina R, Gerel V, Klimtova I, et al. Anthracycline-induced Cardiotoxicity [J]. Actamedica(Hradec Kralove), 2000, 43:75-82.
  • 4Schwarz ER, Pollick C, Dow J, et al. A small animal model of non-ischemic cardiomyopathy and its evaluation by transthoracicechocardiography[J]. Cardiovascular Res, 1998, 39:216 - 223.
  • 5Meune C, Fulla Y, Martins E. et al, B-type natriuretic peptide for the diagnostic and prognostic assessment in cardiology its interest and perspectives of application [J]. Presse Med, 2003, 32: 181-185.
  • 6Martin R.C, Gustavo F.M. BNP and congestive heart failure [J]. Prog Cardiovasc Dis, 2002, 44: 293-321.

共引文献3

同被引文献29

  • 1张仲林,彭成.基因芯片技术在中医药研究领域中的应用[J].中国药科大学学报,2007,38(2):190-192. 被引量:8
  • 2李明华,赵德华,张贵卿.马钱子碱对豚鼠心脏乳头肌动作电位的影响[J].中国药理学通报,1997,13(2):157-159. 被引量:20
  • 3J Robert. Preclinical assessment of anthracycline cardiotoxicity in laboratory animals: Predictiveness and pitfalls [ J ]. Cell Biol Toxicol, 2007,23 : 27-37.
  • 4Van Dartel DAM, Pennings JLA, Robinson JF, et al. Discriminating classes of developmental toxicants usinggene expression profiling in the embryonic stem cell test [ J ]. Toxicol Lett, 2011,201 ( 2 ) : 143-151.
  • 5Evans MJ, KaufmanMH. Establishment in culture of pluripotential cell from mouse embryos [ J ]. Nature, 1981 ,292(5819) :154-156.
  • 6Thomson JA, Itskovitz E J, Shapiro SS , et al. Embryonic Stem Cell line derived from human blastocysts [ J ]. Science, 1998,282 ( 5391 ) : 1145-1147.
  • 7Shamblott M J, Axelman J, Wang S, et al. Derivation of pluripotential stem cells from cultured human primordial germ cells [ J ]. Proc Nat A-cad Sci USA, 1998,95 ( 23 ) : 13726-13731.
  • 8Sarah Adler, Cristian Pellizzer, Lars Hareng, et al. First steps in establishing a developmental toxicity test method based on human embryonic stem ceils[ J]. Toxicol in Vitro, 2008,22( 1 ) :200-211.
  • 9NI zur Nieden, G Kempka, HJ Ahr. Molecular multiple endpoint embryonic stem cell test-a possible approach to test for the teratogenic potential of compounds [ J ]. Toxicol Appl Pharm, 2004,194 ( 3 ) :257- 269.
  • 10Matthias Festag, Bruno Viertel, Pablo Steinberg, et al. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds [ J]. Toxicol in Vitro ,2007,21 ( 8 ) : 1631-1640.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部